Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.10.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Nov. 14, 2017
Jun. 24, 2016
Dec. 20, 2013
Mar. 31, 2017
Jan. 31, 2017
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Mr. Andrew I. Sealfon [Member] | Lease Agreement [Member] | Aircraft [Member]                  
Lease payments           $ 3,876 $ 3,876 $ 7,752 $ 9,251
Mr. Mark Pastreich [Member] | Lease Agreement [Member] | Building [Member]                  
Monthly lease payments $ 12,088         11,042 11,042    
Lease payments           33,126 33,126 66,252 66,252
Property taxes paid           12,720 12,418 25,432 24,585
Brad A. Sealfon [Member]                  
Officer compensation       $ 2,000 $ 5,184        
Clinical Research & Support Services Consulting Agreement [Member] | Dr. Mark Baker [Member]                  
Amortization of deferred compensation cost           0 0 0 7,000
Clinical Research & Support Services Consulting Agreement [Member] | FREEDOM60 Syringe Infusion System [Member] | Dr. Mark Baker [Member]                  
Number of shares issued upon agreement     420,000            
Share price (in dollars per share)     $ 0.20            
Agreement term     3 years            
Consulting Agreement [Member] | Mr. Cyril Narishkin (Consultant) [Member]                  
Monthly payment for agreement   $ 16,000              
Officer compensation           $ 0 $ 0 $ 0 $ 16,000